LENACAPAVIR SODIUM

LENACAPAVIR SODIUM was reported 506 times

LENACAPAVIR SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAL GONOCOCCAL INFECTION 2 0.5000
1 OROPHARYNGEAL GONOCOCCAL INFECTION 1 0.0370
2 INJECTION SITE DISCHARGE 149 0.0277
3 ADMINISTRATION SITE WOUND 2 0.0202
4 ADMINISTRATION SITE DISCHARGE 1 0.0172
5 APPENDICITIS NONINFECTIVE 1 0.0167
6 INJECTION SITE NODULE 113 0.0103
7 INJECTION SITE CELLULITIS 17 0.0091
8 URETHRAL DISCHARGE 1 0.0082
9 PERINEAL RASH 1 0.0081
10 INJECTION SITE MOVEMENT IMPAIRMENT 1 0.0078
11 INJECTION SITE ULCER 7 0.0074
12 LIPOSUCTION 1 0.0065
13 ABDOMINAL WALL WOUND 1 0.0065
14 PRODUCT ADMINISTRATION ISSUE 1 0.0048
15 INJECTION SITE NERVE DAMAGE 1 0.0042
16 FOREIGN BODY REACTION 1 0.0041
17 ACUTE HIV INFECTION 1 0.0040
18 SELF-CONSCIOUSNESS 1 0.0039
19 INJECTION SITE PARAESTHESIA 6 0.0039
20 GONORRHOEA 1 0.0037
21 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 1 0.0036
22 HIV TEST POSITIVE 2 0.0030
23 BODY DYSMORPHIC DISORDER 1 0.0027
24 INJECTION SITE PUSTULE 1 0.0026
25 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
26 INJECTION SITE ABSCESS 6 0.0024
27 INJECTION SITE INFECTION 7 0.0021
28 INJECTION SITE HYPOAESTHESIA 3 0.0021
29 PALATAL DISORDER 1 0.0017
30 SERUM SICKNESS-LIKE REACTION 1 0.0016
31 NASAL CRUSTING 1 0.0015
32 SOFT TISSUE NECROSIS 1 0.0015
33 SYPHILIS 1 0.0014
34 INJECTION SITE INFLAMMATION 5 0.0010
35 INJECTION SITE MASS 37 0.0010
36 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
37 INJECTION SITE DISCOMFORT 10 0.0009
38 INCISION SITE PAIN 1 0.0009
39 INJECTION SITE HYPERSENSITIVITY 2 0.0006
40 PAPILLOMA VIRAL INFECTION 1 0.0006
41 SEIZURE LIKE PHENOMENA 1 0.0006
42 BLOOD CHOLESTEROL DECREASED 1 0.0005
43 EARLY SATIETY 1 0.0005
44 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
45 INJECTION SITE NECROSIS 1 0.0005
46 INJECTION SITE PAIN 141 0.0005
47 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
48 TENDERNESS 4 0.0004
49 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
50 ABDOMINAL MASS 1 0.0004
51 PRESYNCOPE 9 0.0004
52 HYPOMENORRHOEA 1 0.0004
53 INJECTION SITE ERYTHEMA 43 0.0003
54 INJECTION SITE IRRITATION 4 0.0003
55 INJECTION SITE SWELLING 24 0.0003
56 INJECTION SITE INDURATION 4 0.0003
57 EYE MOVEMENT DISORDER 2 0.0003
58 HYPERTRANSAMINASAEMIA 2 0.0003
59 ERYTHEMA NODOSUM 1 0.0003
60 PYODERMA GANGRENOSUM 1 0.0003
61 RECTAL DISCHARGE 1 0.0003
62 VIRAL LOAD INCREASED 1 0.0003
63 INJECTION SITE WARMTH 5 0.0002
64 INJECTION SITE DISCOLOURATION 3 0.0002
65 PRODUCT DISPENSING ISSUE 1 0.0002
66 NODULE 3 0.0002
67 BRAIN NEOPLASM MALIGNANT 1 0.0002
68 INJECTION SITE PAPULE 1 0.0002
69 YELLOW SKIN 1 0.0002
70 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
71 GUILLAIN-BARRE SYNDROME 1 0.0002
72 INJECTION SITE REACTION 14 0.0002
73 ABDOMINAL TENDERNESS 1 0.0002
74 PRODUCT COLOUR ISSUE 1 0.0002
75 INJECTION SITE BRUISING 15 0.0002
76 FOOD POISONING 1 0.0002
77 NONSPECIFIC REACTION 1 0.0002
78 GASTROINTESTINAL PAIN 2 0.0002
79 SKIN WARM 1 0.0002
80 INJECTION SITE VESICLES 1 0.0002
81 PROCTALGIA 1 0.0002
82 PRODUCT PREPARATION ISSUE 1 0.0002
83 SKIN MASS 1 0.0001
84 PRODUCT LABEL ISSUE 1 0.0001
85 ACCIDENTAL UNDERDOSE 2 0.0001
86 INTENTIONAL UNDERDOSE 1 0.0001
87 PAROSMIA 1 0.0001
88 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
89 SYNCOPE 13 0.0001
90 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
91 LOSS OF CONSCIOUSNESS 16 0.0001
92 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
93 PRODUCT COMMUNICATION ISSUE 1 0.0001
94 INJECTION SITE HAEMORRHAGE 9 0.0001
95 DEFORMITY 1 0.0001
96 RECALLED PRODUCT ADMINISTERED 1 0.0001
97 CYTOPENIA 1 0.0001
98 INJECTION SITE PRURITUS 5 0.0001
99 TACHYPNOEA 1 0.0001
100 MASS 1 0.0001
101 URINARY INCONTINENCE 2 0.0001
102 HIP ARTHROPLASTY 1 0.0001
103 INJECTION SITE RASH 2 0.0001
104 DELUSION 1 0.0001
105 PRODUCT USE COMPLAINT 1 0.0001
106 SENSORY DISTURBANCE 1 0.0001
107 MOVEMENT DISORDER 2 0.0001
108 NIGHT SWEATS 2 0.0001
109 MUSCLE TIGHTNESS 1 0.0001
110 PRODUCT STORAGE ERROR 5 0.0001
111 COLD SWEAT 1 0.0001
112 LYMPHADENOPATHY 2 0.0001
113 MUSCULOSKELETAL DISORDER 1 0.0001
114 FEELING JITTERY 1 0.0001
115 CHOKING 1 0.0001
116 ORAL HERPES 1 0.0001
117 CYTOKINE RELEASE SYNDROME 1 0.0000
118 EXTRA DOSE ADMINISTERED 2 0.0000
119 BODY TEMPERATURE INCREASED 1 0.0000
120 IMPAIRED WORK ABILITY 1 0.0000
121 HYPERHIDROSIS 6 0.0000
122 RASH PAPULAR 1 0.0000
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
124 SWELLING 4 0.0000
125 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
126 NEURALGIA 1 0.0000
127 CELLULITIS 2 0.0000
128 ERECTILE DYSFUNCTION 1 0.0000
129 UNRESPONSIVE TO STIMULI 1 0.0000
130 MUSCLE SPASMS 7 0.0000
131 ANHEDONIA 1 0.0000
132 JAUNDICE 1 0.0000
133 BLOOD BILIRUBIN INCREASED 1 0.0000
134 PALLOR 1 0.0000
135 WOUND 1 0.0000
136 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
137 SEIZURE 4 0.0000
138 NEEDLE ISSUE 1 0.0000
139 DYSSTASIA 1 0.0000
140 CHILLS 4 0.0000
141 SURGERY 2 0.0000
142 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
143 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
144 DISCOMFORT 2 0.0000
145 HEAD INJURY 1 0.0000
146 CHOLELITHIASIS 1 0.0000
147 VIRAL INFECTION 1 0.0000
148 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
149 MYALGIA 5 0.0000
150 RESTLESSNESS 1 0.0000
151 EYE SWELLING 1 0.0000
152 UNEVALUABLE EVENT 2 0.0000
153 PALPITATIONS 3 0.0000
154 VOMITING 12 0.0000
155 DISORIENTATION 1 0.0000
156 OSTEOPOROSIS 1 0.0000
157 TREMOR 4 0.0000
158 RHABDOMYOLYSIS 1 0.0000
159 CARDIO-RESPIRATORY ARREST 1 0.0000
160 URTICARIA 4 0.0000
161 SKIN EXFOLIATION 2 0.0000
162 MENTAL DISORDER 1 0.0000
163 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
164 INCORRECT DOSE ADMINISTERED 5 0.0000
165 ABDOMINAL PAIN 5 0.0000
166 PRODUCT USE ISSUE 4 0.0000
167 GAIT DISTURBANCE 4 0.0000
168 DIZZINESS 10 0.0000
169 THERAPY CESSATION 1 0.0000
170 ABDOMINAL PAIN UPPER 4 0.0000
171 ABDOMINAL DISTENSION 2 0.0000
172 DRUG INTERACTION 3 0.0000
173 RASH PRURITIC 1 0.0000
174 ABDOMINAL DISCOMFORT 3 0.0000
175 PRODUCT SUBSTITUTION ISSUE 1 0.0000
176 PYREXIA 6 0.0000
177 NASAL CONGESTION 1 0.0000
178 STOMATITIS 1 0.0000
179 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
180 RHINORRHOEA 1 0.0000
181 NAUSEA 12 0.0000
182 PAIN 9 0.0000
183 THERAPY INTERRUPTED 1 0.0000
184 HYPOAESTHESIA 2 0.0000
185 HALLUCINATION 1 0.0000
186 HOT FLUSH 1 0.0000
187 BACK PAIN 3 0.0000
188 INFLUENZA LIKE ILLNESS 1 0.0000
189 INSOMNIA 3 0.0000
190 TACHYCARDIA 1 0.0000
191 NO ADVERSE EVENT 2 0.0000
192 SUICIDAL IDEATION 1 0.0000
193 NASOPHARYNGITIS 2 0.0000
194 OROPHARYNGEAL PAIN 1 0.0000
195 BREAST CANCER 1 0.0000
196 ANXIETY 3 0.0000
197 CONTUSION 1 0.0000
198 SOMNOLENCE 2 0.0000
199 SINUSITIS 1 0.0000
200 ERYTHEMA 2 0.0000
201 HEADACHE 6 0.0000
202 INFLUENZA 1 0.0000
203 DECREASED APPETITE 2 0.0000
204 PRURITUS 3 0.0000
205 DRY SKIN 1 0.0000
206 PRODUCT QUALITY ISSUE 1 0.0000
207 ARTHRALGIA 3 0.0000
208 DYSPNOEA 4 0.0000
209 PRODUCT DOSE OMISSION ISSUE 2 0.0000
210 PAIN IN EXTREMITY 2 0.0000
211 ACUTE KIDNEY INJURY 1 0.0000
212 CEREBROVASCULAR ACCIDENT 1 0.0000
213 HYPERSENSITIVITY 1 0.0000
214 FATIGUE 4 0.0000
215 HYPOTENSION 1 0.0000
216 DIARRHOEA 3 0.0000
217 RASH 2 0.0000
218 OFF LABEL USE 4 0.0000
219 DEPRESSION 1 0.0000
220 FEELING ABNORMAL 1 0.0000
221 COUGH 1 0.0000
222 CONDITION AGGRAVATED 1 0.0000
223 ASTHENIA 1 0.0000
224 DRUG INEFFECTIVE 2 0.0000